NEWS | SAN DIEGO Ligand earns $2 million in milestone payments from Merck

NEWS | SAN DIEGO Ligand earns $2 million in milestone payments from Merck
San Diego Daily Transcript - 1 hour ago
Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co. Inc. (NYSE: MRK), stemming from its research collaboration ...